Joint Department of Biomedical Engineering, University of North Carolina, Chapel Hill, and North Carolina State University, Raleigh, NC, USA.
Department of Bioengineering, University of Washington, Seattle, WA, USA.
Integr Biol (Camb). 2021 Jun 15;13(6):139-152. doi: 10.1093/intbio/zyab008.
Hyperglycemia is thought to increase production of inflammatory cytokines and permeability of the large intestine. Resulting intestinal inflammation is then often characterized by excess secretion of tumor necrosis factor alpha (TNFα). Thus, hyperglycemia in hospitalized patients suffering from severe trauma or disease is frequently accompanied by TNFα secretion, and the combined impact of these insults on the intestinal epithelium is poorly understood. This study utilized a simple yet elegant model of the intestinal epithelium, comprised of primary human intestinal stem cells and their differentiated progeny, to investigate the impact of hyperglycemia and inflammatory factors on the colonic epithelium. When compared to epithelium cultured under conditions of physiologic glucose, cells under hyperglycemic conditions displayed decreased mucin-2 (MUC2), as well as diminished alkaline phosphatase (ALP) activity. Conditions of 60 mM glucose potentiated secretion of the cytokine IL-8 suggesting that cytokine secretion during hyperglycemia may be a source of tissue inflammation. TNFα measurably increased secretion of IL-8 and IL-1β, which was enhanced at 60 mM glucose. Surprisingly, intestinal permeability and paracellular transport were not altered by even extreme levels of hyperglycemia. The presence of TNFα increased MUC2 presence, decreased ALP activity, and negatively impacted monolayer barrier function. When TNFα hyperglycemia and ≤30 mM glucose and were combined, MUC2 and ALP activity remained similar to that of TNFα alone, although synergistic effects were seen at 60 mM glucose. An automated image analysis pipeline was developed to assay changes in properties of the zonula occludens-1 (ZO-1)-demarcated cell boundaries. While hyperglycemia alone had little impact on cell shape and size, cell morphologic properties were extraordinarily sensitive to soluble TNFα. These results suggest that TNFα acted as the dominant modulator of the epithelium relative to glucose, and that control of inflammation rather than glucose may be key to maintaining intestinal homeostasis.
高血糖被认为会增加炎症细胞因子的产生和大肠的通透性。由此导致的肠道炎症通常表现为肿瘤坏死因子 α(TNFα)的过度分泌。因此,患有严重创伤或疾病的住院患者的高血糖常伴有 TNFα 的分泌,而这些损伤对肠道上皮的综合影响还知之甚少。本研究利用一个简单而优雅的肠道上皮模型,由原代人肠道干细胞及其分化后代组成,来研究高血糖和炎症因子对结肠上皮的影响。与在生理葡萄糖条件下培养的上皮相比,高血糖条件下的细胞显示粘蛋白 2(MUC2)减少,碱性磷酸酶(ALP)活性降低。60mM 葡萄糖条件下细胞分泌细胞因子 IL-8 的能力增强,提示高血糖时细胞因子的分泌可能是组织炎症的一个来源。TNFα可测量地增加了 IL-8 和 IL-1β的分泌,而在 60mM 葡萄糖条件下这种作用增强。令人惊讶的是,即使是极高水平的高血糖也不会改变肠道通透性和细胞旁转运。TNFα的存在增加了 MUC2 的存在,降低了 ALP 活性,并对单层屏障功能产生负面影响。当 TNFα、高血糖和≤30mM 葡萄糖同时存在时,MUC2 和 ALP 活性与单独 TNFα相似,尽管在 60mM 葡萄糖条件下存在协同作用。开发了一个自动图像分析管道来检测紧密连接蛋白-1(ZO-1)界定的细胞边界的特性变化。虽然高血糖本身对细胞形状和大小的影响很小,但细胞形态特性对可溶性 TNFα非常敏感。这些结果表明,与葡萄糖相比,TNFα是上皮的主要调节剂,控制炎症而不是葡萄糖可能是维持肠道内稳态的关键。